Expansion of CAG trinucleotide repeats that encode polyglutamine is the underlying cause of at least nine inherited human neurodegenerative disorders, including Huntington's disease and spinocerebellar ataxias. PolyQ fragments accumulate as aggregates in the cytoplasm and/or in the nucleus, and induce neuronal cell death. However, the molecular mechanism of polyQ-induced cell death is controversial. Here, we show the following: (1) polyQ with pathogenic repeat length triggers ER stress through proteasomal dysfunction; (2) ER stress activates ASK 1 through formation of an IRE1-TRAF2-ASK1 complex; and (3) ASK1 −/− primary neurons are defective in polyQ-, proteasome inhibitor-, and ER stress-induced JNK activation and cell death. These findings suggest that ASK1 is a key element in ER stress-induced cell death that plays an important role in the neuropathological alterations in polyQ diseases.
Expanded polyglutamine (polyQ) is now known to be the cause of nine inherited neurodegenerative disorders, including Huntington's disease (HD), spinobulbar muscular atrophy (SBMA), dentatorubral-pallidoluysian atrophy (DRPLA), and six spinocerebellar ataxias (SCAs 1, 2, 6, 7, 17, and SCA3/Machado-Joseph disease [MJD] ). PolyQ fragments derived from the full-length protein associated with each of the polyQ diseases have been shown to form intracellular aggregations and to produce toxic effects (Kakizuka 1998; Paulson et al. 2000) as observed in cultured cells and transgenic animals overexpressing polyQ proteins (Ikeda et al. 1996; Jackson et al. 1998; Warrick et al. 1999; Kazemi-Esfarjani and Benzer 2000; Satyal et al. 2000) and in postmortem brain of polyQ diseases patients (DiFiglia et al. 1997; Paulson et al. 1997) . Genetic and molecular studies suggest that polyQ causes alteration of gene expression, abnormal protein interactions, alteration of proteolysis, and activation of caspases and protein unfolding (Paulson et al. 2000; McCampbell and Fischbeck 2001; Nucifora et al. 2001) . However, the causal relation between these cellular events and the pathogenesis has not been elucidated.
Recent studies suggested that polyQ fragments with pathogenic repeat lengths are colocalized with various molecular chaperons and proteasome components (e.g., HSP70, HSP40, 20S, and 19S) (Waelter et al. 2001 ) and impair the function of the ubiquitine-proteasome systems (UPS) (Bence et al. 2001; Jana et al. 2001; Waelter et al. 2001) . Because UPS normally control the quality of proteins by degradation, the blockage of UPS by polyQ might result in the accumulation of misfolded proteins that are produced at the normal protein turnover. Importantly, elevated levels of chaperones and proteasome subunits were shown to mitigate the toxic effects of polyQ (Warrick et al. 1999; Kazemi-Esfarjani and Benzer 2000) . These observations suggest a functional link between proteasomal dysfunction and accumulation of misfolded proteins in the context of polyQ-induced neurotoxicity (Orr 2001; Sherman and Goldberg 2001) . However, it is unclear how polyQ-induced proteasomal dysfunction and protein unfolding can be molecularly converted to neuronal cell death.
Accumulation of unfolded proteins within the endoplasmic reticulum (ER) lumen induces ER stress, and ER stress has been recently implicated in human diseases such as Alzheimer's disease (Katayama et al. 1999; Nakagawa et al. 2000 ), Parkinson's disease (Imai et al. 2001) and diabetes mellitus (Delepine et al. 2000; Harding et al. 2001) . Initial mediators of ER stress responses are ERresident type I transmembrane serine/threonine protein kinases, PERK and IRE1; accumulation of unfolded proteins in ER induces oligomerization-dependent autophosphorylation of these kinases Liu et al. 2000) , and thereby initiates cytoplasmic signal transduction. It was shown recently that activated IRE1 on ER membrane recruits TNF receptor-associated factor 2 (TRAF2) and thus activates c-Jun amino-terminal kinase (JNK) (Urano et al. 2000b ). In addition, overexpression of IRE1 induced apoptosis in HeLa cells (Iwawaki et al. 2001 ). Nevertheless, a direct target of IRE1-TRAF2 complex in the ER stress-induced JNK-signaling pathway is unknown.
We have shown previously that the mammalian mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) termed apoptosis signal-regulating kinase (ASK1) directly interacts with TRAF2 and constitutes a TRAF2-ASK1-SEK1/MKK4-JNK cascade in TNF signaling . ASK1 is activated in response to various stimuli through distinct mechanisms and relays those signals to the stress-activated protein kinases, JNK and p38 Saitoh et al. 1998; Tobiume et al. 2001) . Overexpression of ASK1 induces apoptosis in various cells through mitochondria-dependent caspase activation (Ichijo et al. 1997; Saitoh et al. 1998; Hatai et al. 2000) . Recently, we have shown that by deleting ASK1 in mice, TNF-and H 2 O 2 -induced apoptosis are suppressed in ASK1 −/− cells (Tobiume et al. 2001 ). These observations suggest that ASK1 plays essential roles in stress-induced apoptosis.
In the present study, we investigated the role of ASK1 in the pathogenesis of polyQ diseases. PolyQ fragments with pathogenic repeat length inhibited proteasomal activity and thereby induced ER stress. Activated IRE1 by polyQ induced the TRAF2-ASK1 complex formation that led to JNK activation. We show that primary neurons derived from ASK1 −/− mice were resistant to ER stress-, proteasome dysfunction-, and polyQ-induced JNK activation and cell death. ASK1 thus mediates proteasome dysfunction-and ER stress-induced neuronal cell death, which plays an important role in the neuropathological alterations in polyQ diseases.
Results

PolyQ triggers ER stress
The molecular mechanism by which expanded polyQ induces neuronal cell death is not fully understood. To investigate the causal relation between polyQ, ER stress, and neuronal cell death, we first examined whether polyQ induces ER stress as assessed by the band-shift analyses of ER-resident transmembrane kinases, IRE1 and PERK. We have previously established PC12 cell lines that express normal length polyQ (Q14) or pathogenic length polyQ (Q79) derived from carboxy-terminal fragments of the SCA3/MJD proteins under the control of tetracycline (Tet)-repressive promoter (Yasuda et al. 1999) . Upon induction by Tet removal, Q79, but not Q14, formed polyQ aggregates (see below). IRE1 was detected as a doublet band without the induction of polyQ in both PC12-Q79 and PC12-Q14 cells (Fig. 1A, top,  lanes 1,5) . On the other hand, induction of Q79, but not Q14, resulted in a shifted single band of IRE1 (Fig. 1A,  lanes 3 ,4,7,8) , which represents the autophosphorylated, and thus activated, form of IRE1 (Urano et al. 2000b) . PERK was also activated by Q79, as determined by a similar band-shift analysis (Fig. 1A, bottom) . Q79-specific induction of CHOP (another ER stress marker protein, also termed GADD153) was also observed (Fig. 1B,  lanes 3,4) . Thapsigargin, which triggers ER stress by depletion of lumenal calcium stores, induced IRE1/ PERK activations (Fig. 1A , lanes 2,6) and CHOP (Fig. 1B , lanes 2,6) in both PC12-Q79 and PC12-Q14 cells. This indicates that the Q79-specific activation of ER stress markers was not due to the clonal differences between PC12-Q79 and PC12-Q14 cells. To confirm these results in the more physiological conditions, we assessed the effect of polyQ on primary neurons derived from E14.5 mice. Adenovirus-mediated expression of Q79 (Ad-Q79), but not control ␤-galactosidase (Ad-␤-gal) or Q35 (Ad-Q35; another SCA3/MJD-derived polyQ fragments within nonpathogenic repeat length; Ikeda et al. 1996) activated IRE1 and PERK (Fig. 1C, lanes 1-4) and induced the mRNAs of BiP (another ER stress marker; also known as GRP78) and CHOP (Fig. 1D, lanes 1-4) in neurons. These results indicate that polyQ aggregation causes ER stress in neuronal cells.
Proteasomal dysfunction involved in polyQ-induced ER stress
ER stress is induced by the accumulation of unfolded proteins within the ER lumen (Kaufman 1999; Urano et al. 2000a) . Because polyQ peptide itself has neither a signal sequence nor transmembrane segment, it is unlikely that polyQ directly triggers ER stress within the ER. On the other hand, polyQ has been suggested recently to impair proteasomal activity in neuronal and non-neuronal cell lines (Bence et al. 2001; Jana et al. 2001; Orr 2001; Sherman and Goldberg 2001; Waelter et al. 2001 ). In addition, proteasome inhibition has been reported to induce ER chaperones in non-neuronal cells (Bush et al. 1997) . Because misfolded proteins in the secretory pathway are normally exported from the ER back into the cytosol, where they are rapidly degraded by UPS (Johnson and Haigh 2000) , disturbance of UPS by polyQ may lead to accumulation of unfolded proteins within the ER and, thus, to induce ER stress. We therefore examined whether alteration of proteasome activity was involved in the polyQ-induced ER stress. Ad-Q79, but not control Ad-␤-gal or Ad-Q35 (data not shown) significantly inhibited the proteasome activity in mouse pri-mary neurons (Fig. 1E) . Considering the infection efficiency of Ad-Q79 in MAP2-positive primary neurons (∼70% at m.o.i. 100; data not shown), the inhibitory effect of Ad-Q79 at m.o.i. 100 after 96 h appeared to be comparable with that of 0.1 µM or more of MG132 (a proteasome inhibitor) (Fig. 1E) . Although the exact target of polyQ in the UPS remains unknown from these experiments, these results suggest that pathogenic polyQ impairs the function of UPS as has been suggested by use of different systems (Bence et al. 2001; Jana et al. 2001; Orr 2001; Sherman and Goldberg 2001; Waelter et al. 2001) . To examine whether inhibition of proteasome activity may cause ER stress, the effects of proteasome inhibitor on the ER were assessed. When neurons were incubated with 0.1 µM MG132 for 48 h, the activations of IRE1 and PERK (Fig. 1C, lane 5) as well as the inductions of BiP and CHOP (Fig. 1D , lane 5) were clearly induced. These results suggest that polyQ triggers ER stress at least in part through proteasomal dysfunction.
ER stress activates ASK1 through IRE1-TRAF2-ASK1 complex formation
ER stress-activated IRE1 was shown recently to recruit TRAF2 on ER membrane and, thus, to activate JNK (Urano et al. 2000b ); however, the molecular link be- 
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tween the IRE1-TRAF2 complex and the JNK in ER stress signaling is missing. Because ASK1 interacts with TRAF2 upon TNF treatment and constitutes a TRAF2-ASK1-SEK1/MKK4-JNK cascade in the TNF-signaling pathway , we investigated whether ASK1 was also involved in ER stress signaling. We first examined the effect of ER stressors on the catalytic activity of ASK1 by using an antiphospho-ASK1 antibody that monitors activating phosphorylation of ASK1 (Tobiume et al. 2002) . Treatment of PC12 cells with thapsigargin or tunicamycin (an inhibitor of N-glycosylation in ER) activated endogenous ASK1 as well as JNK ( Fig.  2A ), indicating that ER stress activates the ASK1-JNK pathway.
Next, we examined the association of endogenous ASK1 and TRAF2 in untransfected PC12 cells. Anti-ASK1 antiserum specifically immunoprecipitated and detected the endogenous ASK1 protein as a major dou- blet of bands (Fig. 2B, lane 2) . When lysates from thapsigargin-or tunicamycin-treated cells were immunoprecipitated with anti-TRAF2 antiserum and immunoblotted with anti-ASK1 antiserum, ASK1 was found to associate with TRAF2 in an ER stress-dependent manner (Fig. 2B, lanes 5-7) . This interaction was observed within 15 min and continued until 60 min after treatment with thapsigargin, which correlates well with the time course of thapsigargin-induced activation of ASK1 and JNK ( Fig.  2A) . Activation of IRE1 and complex formation of endogenous TRAF2 and ASK1 were also observed in thapsigargin-treated primary neurons (Fig. 2E, lane 3) . These results suggest that ER stress activates the ASK1-JNK pathway through induction of the TRAF2-ASK1 complex. To investigate whether IRE1 recruits TRAF2 and ASK1 in an ER stress-dependent manner, Myc-ASK1, HA-IRE1, and Flag-TRAF2 were transfected into 293 cells and subjected to coimmunoprecipitation analysis (Fig. 2C) . ASK1 was found to associate with IRE1 only in the presence of TRAF2 plus thapsigargin (Fig. 2C , top, lane 8), suggesting that ER stress induces formation of an IRE1-TRAF2-ASK1 complex on the ER outer membrane and thus activates the ASK1-JNK pathway.
Expanded polyQ activates ASK1 through ER stress
We next examined whether polyQ with pathogenic repeat length activates ASK1. Induction of Q79, but not Q14, activated endogenous ASK1 in PC12 cells after 6 h of Tet removal (Fig. 2D , top, for PC12-Q79). JNK was activated in parallel with this. The onset of polyQ aggregation (Fig. 2D , bottom, for PC12-Q79; aggregates can be detected by immunoblotting of stacking gel) coincided with the activation of ASK1 and JNK. To confirm that the polyQ-induced activation of ASK1 was mediated by the polyQ-induced ER stress, we examined whether polyQ induces the interaction between endogenous ASK1 and TRAF2 in mouse primary neurons. ASK1 was found to associate with TRAF2 in the cells infected with Ad-Q79 but not Ad-␤-gal (Fig. 2E, top, lanes 1,2) . Taken together, these findings indicate that pathogenic polyQ activated the ASK1-JNK pathway by triggering ER stress.
ASK1 is required for ER stress-and proteasomal dysfunction-induced JNK activation
ASK1 is required for TNF-and oxidative stress-induced activation of JNK and apoptosis (Ichijo et al. 1997; Saitoh et al. 1998; Tobiume et al. 2001) . We assessed the requirement of ASK1 for ER stress-and proteasomal dysfunction-induced JNK activation by using MEFs and primary neurons derived from ASK1 −/− mice. Activation of endogenous JNK by thapsigargin and MG132 was almost completely eliminated in ASK1 −/− MEFs (Fig. 3A,B ) and ASK1 −/− primary neurons (Fig. 4D, lanes 2,3,8,9 ). Overexpression of IRE1 activated the cotransfected JNK in ASK1 +/+ MEFs but not at all in ASK1 −/− MEFs (Fig. 3C ).
Reintroduction of ASK1 in ASK1
−/− MEFs restored JNK activation (Fig. 3D, lanes 5,10) , suggesting that downstream components of ASK1 are intact in ASK1 −/− MEFs. TRAF2-induced maximal activation of JNK in ASK1 +/+ MEFs (2.9-fold) was reduced (1.3-fold) but not completely lost in ASK1 −/− MEFs (Fig. 3D, lanes 2-4,7-9 ). This residual JNK activation by TRAF2 in ASK −/− MEFs may occur via a redundant pathway involving GCK/GCKR-MEKK1, which operates in TRAF2-mediated TNF signaling (Yuasa et al. 1998 ). Consistently, TNF-induced JNK activation was partially, but not completely, lost in ASK1 −/− MEFs (Tobiume et al. 2001) . These results rather demonstrate a nonredundant and highly specific role of ASK1 in ER stress-induced JNK activation.
ASK1 is required for ER stress-and proteasomal dysfunction-induced cell death
We next examined whether ASK1 is required for ER stress-and proteasomal dysfunction-induced cell death. Apoptotic cell death was clearly induced by thapsigargin in ASK1 +/+ MEFs, as determined by cell morphology (Fig.  3E , panels a,c,e,g) and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining (Tobiume et al. 2001) (Fig. 3E, panels b,d ,f,h). Within 6 h after treatment with thapsigargin, nearly 100% of ASK1 +/+ MEFs became TUNEL positive (Fig. 3F ); in contrast, ASK1 −/− MEFs were almost completely resistant to thapsigargin-induced apoptosis (Fig. 3E,F) . ASK1 −/− MEFs were also resistant to other ER stressors including tunicamycin and dithiothreitol, as determined by 3Ј-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay (data not shown). Proteasomal dysfunction has been reported to induce apoptosis in various cell types including neuronal cells (Sadoul et al. 1996; Drexler 1997; Qiu et al. 2000) . We examined whether ASK1 is required for apoptosis induced by the proteasome inhibitors. ASK1 −/− and ASK1 +/+ MEFs were incubated with various proteasome inhibitors, including MG132, Lactacystin, and Proteasome inhibitor I; apoptotic cell death was analyzed by TUNEL assay. Proteasome inhibitor-induced apoptosis in ASK1 −/− MEFs were significantly lower than that in ASK1 +/+ MEFs (Fig. 3G ). The requirement of ASK1 for ER stress-and proteasomal dysfunction-induced cell death was also shown in the primary neurons as determined by an MTT assay (Fig.  4A-C) . These results indicate that ASK1 is an essential component of the ER stress-and proteasomal dysfunction-induced cell death.
ASK1 is required for polyQ-induced neuronal cell death
Next, we examined the requirement of ASK1 for polyQinduced JNK activation and neuronal cell death. Because JNK3 is selectively expressed in the brain and implicated in excitotoxicity-induced neuronal cell death (Yang et al. 1997) , we determined the JNK3 activity in ASK1 +/+ and ASK1 −/− primary neurons. Ad-Q79 activated JNK3 in ASK1 +/+ primary neurons in an m.o.i.-dependent man- ner, whereas no increase in JNK3 activity was observed in ASK1 −/− neurons (Fig. 4D, lanes 4 ,5,10,11). Neither Ad-␤-gal nor Ad-Q35 activated JNK3 (Fig. 4D, lane 6 ; data not shown) in ASK1 +/+ primary neurons. ASK1
−/− neurons were also insensitive to thapsigargin and MG132 in JNK3 activation (Fig. 4D, lanes 2,3,8,9 ). These results indicate that ASK1 is required for JNK3 activation by pathogenic polyQ. PolyQ-induced cell death was determined by MTT assay (Fig. 4E) . Q79, but not Q35, induced cell death in ASK1 +/+ neurons. ASK1 −/− neurons were clearly more resistant to Q79-induced cell death than ASK1 +/+ neurons (Fig. 4E) , indicating that ASK1 is required for polyQ-induced neuronal cell death.
Discussion
We have identified ASK1 as an essential component in the neuronal death signaling induced by expanded polyQ. Expanded polyQ has been known to cause various cellular events, including alteration of gene expression, abnormal protein interaction, and activation of caspase (Lin et al. 1999; Paulson et al. 2000) , and all of these abnormal alterations potentially trigger neuronal cell death (Fig. 5) . However, direct genetic evidence has never been provided to the hypothetical involvement of these events in the polyQ-induced cell death pathway. In the present study, we have shown that polyQ induces ER 
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stress, which in turn activates the IRE1-TRAF2-ASK1-JNK-signaling pathway leading to neuronal cell death (Fig. 5) . The almost complete loss of JNK activation (Figs.  3A, 4D ) and cell death (Figs. 3E,F, 4A,B) induced by ER stressors in ASK1 −/− cells strongly argues that ASK1 constitutes an essential and nonredundant cell death pathway in response to ER stress.
Recent studies have suggested that polyQ disturbs UPS (Bence et al. 2001; Jana et al. 2001; Waelter et al. 2001) , and thus compromise its ability to degrade not only polyQ but also unfolded proteins produced at a normal protein turnover. UPS dysfunction has been implicated in the pathogenesis of various neurodegenerative diseases (Sherman and Goldberg 2001) such as amyotrophic lateral sclerosis (Johnston et al. 2000) and Parkinson's disease (Imai et al. 2001) . However, the molecular mechanism by which polyQ-induced UPS dysfunction leads to neuronal cell death has remained unknown. Although polyQ-induced inhibition of the proteasome activity in primary neurons were incomplete (∼30% at most by Ad-Q79 at m.o.i. of 100; Fig. 1E ), such an extent of proteasome dysfunction was sufficient to cause ER stress (Fig. 1C,D) and neuronal cell death (Fig. 4C) . These results suggested that polyQ-induced proteasomal dysfunction and neuronal cell death can be linked by the ER stress-dependent cell death pathway. Consistently, activations of JNK by polyQ or proteasome inhibitors were completely abrogated in ASK1 −/− cells (Figs. 3B, 4D) , and ASK1 −/− cells were refractory to polyQ-and proteasome inhibitor-induced apoptosis (Figs. 3G, 4C,E) . This indicates that ASK1 is a key component in the polyQ-initiated cell death signaling cascade involving UPS dysfunction and ER stress (Fig. 5) . On the other hand, resistance to proteasome inhibitor-induced apoptosis in ASK1 −/− cells was not as dramatic as that to ER stress-induced apoptosis (Figs. 3G, 4C ). These results suggest that ASK1-JNK-and ER stress-independent cell death pathway may also exist in the downstream of proteasome dysfunction. This may also reflect, in part, the incomplete resistance of ASK1 −/− neurons to polyQ-induced cell death (Fig. 4E) .
It has been suggested that neuronal cell death may not be necessary for the trigger of atrophy and ataxia. This hypothesis is supported by a recent study that showed the reversal motor dysfunction in a conditional HD model mouse in which expression of polyQ proteins were regulated by tetracycline-repressor (Yamamoto et al. 2000) . In this mouse model, expression of polyQ induced HD-like phenotype without a significant decrease in neuron number, and blockade of expression of polyQ leads to disappearance of aggregation and an amelioration of the behavioral phenotype. Thus, polyQ-induced neuronal cell death might not be a primary event required for the initiation of polyQ diseases phenotype. Nevertheless, considering the slow progressive nature of the human polyQ diseases accompanied by substantial loss of neurons, it is unlikely that polyQ diseases can eventually be cured without prevention of neuronal cell death. In this regard, whether ASK1 deficiency mitigates polyQ disease phenotype in appropriate mouse models will be an interesting issue to be examined.
Another important issue to be elucidated is the relation between the ASK1-JNK pathway and caspase12, which has been reported to be essential for ER stressinduced apoptosis and neurotoxicity by amyloid-␤ proteins (Nakagawa et al. 2000) . It is currently unclear whether the ASK1-JNK cascade is required for caspase12 activation, or vice versa. However, whereas ASK1 is activated within 15 min in response to ER stress, caspase12 activation occurs much slower after increase in production of inactive caspase12 precursor . ASK1 may thus lie upstream of caspase12. Alternatively, these two cascades might contribute independently to different neurodegenerative disorders (e.g., Alzheimer's disease and polyQ diseases).
Here, we propose a novel mechanism by which expanded polyQ repeats cause neuronal cell death through UPS dysfunction, ER stress, and the ASK1-JNK pathway. Exactly how pathogenic polyQ compromises UPS that is required for ER-associated degradation (ERAD) also remains to be elucidated. However, recent findings that a complex of Cdc48/p97/VCP (an AAA ATPase family member), Udf1 (a protein involved in the degradation of ubiquitin fusion proteins at post-ubiquitination steps), and Npl4 is required for the extraction of proteins from the ER to cytosol (Ye et al. 2001) , and that Cdc48/p97/ VCP interacts and colocalizes with expanded polyQ (Hirabayashi et al. 2001) , suggest that polyQ might thus target an ERAD-specific UPS involving the Cdc48/p97/ VCP-Udf1-Npl4 complex. Because dysfunctions of UPS and the ER appear to be involved in the pathogenesis of many neurodegenerative diseases, ASK1 may be a potential therapeutic target for various neurodegenerative disorders represented by polyQ diseases.
Materials and methods
Cells and cell cultures
PC12 cells, PC12-Q79 and PC12-Q14, were maintained as described (Yasuda et al. 1999) . ASK1 −/− and ASK1 +/+ MEFs were obtained from E12.5 embryos (Tobiume et al. 2001) . For primary neurons, telencephalons from E14.5 mice were triturated in HBSS by mild and frequent pipetting. Dissociated cells were cultured in N2-supplemented DMEM-F12 medium on assay plates precoated with poly-L-ornithine and fibronectin.
Expression plasmid and transfection
pBabe-IRE1␤ was obtained from D. Ron (Urano et al. 2000b ). pcDNA3-Flag-TRAF2 ), pcDNA3-HA-ASK1 , and pcDNA3-HA-JNK ) have been described. HA-IRE1␤, Myc-TRAF2, and Myc-ASK1 were constructed in pcDNA3 (Invitrogen) by PCR. Transfection was performed with FuGENE6 (Roche) according to the manufacturer's instructions.
Antibodies
Rabbit polyclonal antiserum to phospho-ASK1 was directed against a phosphorylated peptide fragment of mouse ASK1 (the peptide sequence C 842 TETFTGTLQY 852 containing phosphorylated Thr 845 that is essential for ASK1 activation; Tobiume et al. 2002) . Specific antibody was affinity purified by use of phosphorylated and nonphosphorylated peptide columns. Antiserum to ASK1 (DAV) has been described ). Antisera to IRE1␣, IRE1␤, PERK, and CHOP were obtained from D. Ron.
Infection of recombinant adenoviruses
Recombinant adenoviruses encoding Flag-Q79 and ␤-galactosidase were constructed as described . Primary neurons were cultured in N2-supplemented DMEM-F12 medium for 6 h and infected with recombinant adenoviruses. About 70% of primary neurons can be successfully infected at a multiplicity of infection (m.o.i.) of 100 as determined by immunocytochemistry with antibodies to MAP2 (Sigma) and Flag (M2) (data not shown).
Proteasomal assay
Approximately 6 × 10 5 primary neurons were lysed in the CHAPS buffer containing 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 0.2% CHAPS, 5 mM EDTA, 1 mM EGTA, 3 mM NaN 3 , and protease inhibitor cocktail (Sigma) after infection with recombinant adenoviruses or stimulation with MG132 (Calbiochem), and cell extracts were clarified by centrifugation. For measurement of the chymotrypsin-like peptidase activity of the proteasome, Succinil-Leu-Leu-Val-Tyr-7 amino-4-methylcoumarin (Suc-LLVY-AMC; Bachem) was taken from a stock of 40 mM (DMSO) to yield a final concentration of 50 µM. Substrate were diluted in 50 mM Tris-HCl (pH 7.3), 100 mM NaCl, 5 mM EDTA, 1 mM EGTA, 3 mM NaN 3 , and 2 mM DTT. A total of 80 µL of cell extract were incubated with 100 µL of substrate solution for 15 min at 37°C. Fluorescence of the released AMC was measured with an excitation wavelength of 380 nm and emission wavelength of 440 nm (CytoFluor2350; Millipore).
RT-PCR
Total RNA was isolated from 6 × 10 5 primary neurons using ISOGEN kit (Nippongene). RNA (10 µg) was reverse transcribed with SuperScript II (Life Technologies) according to the manufacturer's instructions. The primers used for PCR were as follows. BiP, 5Ј-AAGGTCTATGAAGGTGAACGACCCC-3Ј and 5Ј-GACCCCAAGACATGTGAGCAACTGC-3Ј; CHOP, 5Ј-AC-TACTCTTGACCCTGCGTCCCTAG-3Ј and 5Ј-CATGTG-CAGTGCAGTGCAGGGTCAC-3Ј; and G3PDH (Clontech).
Immunoblotting analysis
Immunoblotting analysis has been described (Tobiume et al. 2001) . Blots were probed with antibodies to JNK1 (Santa Cruz), phospho-JNK (Cell Signaling), ASK1, phospho-ASK, and CHOP.
Band-shift analysis for IRE1 and PERK
Approximately 5 × 10 6 PC12-Q79 and PC12-Q14 cells were washed with PBS and cultured in DMEM containing 1% HS without Tet. Cells were lysed in the lysis buffer as described . Cell extracts were clarified by centrifugation, and the supernatants were immunoprecipitated with an-ASK1 in ER stress and polyQ disease tisera to IRE1␣ and PERK. Proteins were resolved by SDS-PAGE under reducing conditions and immunoblotted with antisera to IRE1␣ and PERK.
Coimmunoprecipitation analysis
Coimmunoprecipitation analysis using transfected 293 cells has been described ). For endogenous coimmunoprecipitation analysis, 5 × 10 6 of nontransfected PC12 cells and 1 × 10 7 primary neurons were lysed in the lysis buffer after stimulation with thapsigargin or tunicamycin and infection with recombinant adenoviruses, respectively. Cell lysates were immunoprecipitated with antibodies to ASK1 or TRAF2 (Upstate Biotechnology). Proteins were resolved by SDS-PAGE and immunoblotted with antibody to ASK1.
Immunecomplex kinase assay for JNK
Approximately 1.5 × 10 7 MEFs in 15-cm diameter plates were transiently transfected with the expression vectors using Fu-GENE6. After 48 h, cells were lysed with the lysis buffer and immunoprecipitated with anti-HA antibody (12CA5; Roche). For JNK3 kinase assay, 2 × 10 6 primary neurons were infected with recombinant adenoviruses. After 48 h, cells were lysed with the lysis buffer and immunoprecipitated with anti-JNK3 antibody (Transduction Laboratories). The kinase assay using GST-cJun (1-79) has been described ). The amount of JNK protein was determined by immunoblotting with anti-HA antibody (3F10; Roche) or antibody to JNK1 (Santa Cruz), and quantified by densitometric analysis (Quantity One program; pdi).
MTT assay
Cell viability of primary neurons was determined as described (Tobiume et al. 2001) . The relative number of surviving cells was determined in triplicate by estimating the value of unstimulated or uninfected cells as 100%. Thus, onefold means that 100% of cells are viable as compared with control.
